Response to “The common drug review: A NICE start for Canada?” [Health Policy 77(3) (2006) 339–51]

Response to “The common drug review: A NICE start for Canada?” [Health Policy 77(3) (2006) 339–51]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Health policy (Amsterdam) 2007-01, Vol.80 (1), p.1-1
Hauptverfasser: Lee, Karen Mimi, la Fleur, D. Philip
Format: Artikel
Sprache:eng
Schlagworte:
Canada
Drug and Narcotic Control - organization & administration
Health administration
Internal Medicine
National Health Programs
Policy Making
Reimbursement Mechanisms - standards
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1
container_issue 1
container_start_page 1
container_title Health policy (Amsterdam)
container_volume 80
creator Lee, Karen Mimi
la Fleur, D. Philip
description
doi_str_mv 10.1016/j.healthpol.2006.02.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68352367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0168851006000327</els_id><sourcerecordid>68352367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-ae8aeb10c36a731a7cdf55cbd2cf1ed9e4ae7a636fc77c3c316565d4aa020f273</originalsourceid><addsrcrecordid>eNqNUsGO0zAQjRCILQu_AD6h3UOCHSd2ygFUVQtdaQUIlhNClutMiEsSBztZ1Fv_gSv8XL-ECa0WiROHmXd5b_TmzUTRE0YTRpl4tklq0M1Q965JUkpFQtME4U40Y4VMY0Hz7G40Q2YRFzmjJ9GDEDaUUsm5uB-dMJHPZSb5LKrfQ-hdF4AMjux3P69rIMa1retI6ccvxMONhe_PyYK8uVxekDBoP5DKebLUnS71y_3uF_m0-uOFvHONNVsi5Rk_J2eTrXPC-Xy_-5Gzzw-je5VuAjw64mn08dXF9XIVX719fblcXMUm4_kQayg0rBk1XGjJmZamrPLcrMvUVAzKOWQapBZcVEZKww3HVUReZlrTlFap5KfR08Pc3rtvI4RBtTYYaBrdgRuDEgXPUy4mojwQjXcheKhU722r_VYxqqaQ1UbdhqymbRRNFQIqVwelhx7MrQwAakCuVTeK64Ji22KhUiJYLIbVH1AUqh5aHPX46HZct1D-tXA8EBIWBwJgZngKr4Kx0BkorQczqNLZ__D74p8ZprGdNbr5ClsIGzf6Dk-imAooUB-mt5m-hgr8GI6Z_gbbqr8Z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68352367</pqid></control><display><type>article</type><title>Response to “The common drug review: A NICE start for Canada?” [Health Policy 77(3) (2006) 339–51]</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><source>RePEc</source><creator>Lee, Karen Mimi ; la Fleur, D. Philip</creator><creatorcontrib>Lee, Karen Mimi ; la Fleur, D. Philip</creatorcontrib><identifier>ISSN: 0168-8510</identifier><identifier>EISSN: 1872-6054</identifier><identifier>DOI: 10.1016/j.healthpol.2006.02.006</identifier><identifier>PMID: 16597473</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Canada ; Drug and Narcotic Control - organization &amp; administration ; Health administration ; Internal Medicine ; National Health Programs ; Policy Making ; Reimbursement Mechanisms - standards</subject><ispartof>Health policy (Amsterdam), 2007-01, Vol.80 (1), p.1-1</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2006 Elsevier Ireland Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c435t-ae8aeb10c36a731a7cdf55cbd2cf1ed9e4ae7a636fc77c3c316565d4aa020f273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.healthpol.2006.02.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,4007,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16597473$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://econpapers.repec.org/article/eeehepoli/v_3a80_3ay_3a2007_3ai_3a1_3ap_3a1-368.htm$$DView record in RePEc$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Karen Mimi</creatorcontrib><creatorcontrib>la Fleur, D. Philip</creatorcontrib><title>Response to “The common drug review: A NICE start for Canada?” [Health Policy 77(3) (2006) 339–51]</title><title>Health policy (Amsterdam)</title><addtitle>Health Policy</addtitle><subject>Canada</subject><subject>Drug and Narcotic Control - organization &amp; administration</subject><subject>Health administration</subject><subject>Internal Medicine</subject><subject>National Health Programs</subject><subject>Policy Making</subject><subject>Reimbursement Mechanisms - standards</subject><issn>0168-8510</issn><issn>1872-6054</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>X2L</sourceid><recordid>eNqNUsGO0zAQjRCILQu_AD6h3UOCHSd2ygFUVQtdaQUIlhNClutMiEsSBztZ1Fv_gSv8XL-ECa0WiROHmXd5b_TmzUTRE0YTRpl4tklq0M1Q965JUkpFQtME4U40Y4VMY0Hz7G40Q2YRFzmjJ9GDEDaUUsm5uB-dMJHPZSb5LKrfQ-hdF4AMjux3P69rIMa1retI6ccvxMONhe_PyYK8uVxekDBoP5DKebLUnS71y_3uF_m0-uOFvHONNVsi5Rk_J2eTrXPC-Xy_-5Gzzw-je5VuAjw64mn08dXF9XIVX719fblcXMUm4_kQayg0rBk1XGjJmZamrPLcrMvUVAzKOWQapBZcVEZKww3HVUReZlrTlFap5KfR08Pc3rtvI4RBtTYYaBrdgRuDEgXPUy4mojwQjXcheKhU722r_VYxqqaQ1UbdhqymbRRNFQIqVwelhx7MrQwAakCuVTeK64Ji22KhUiJYLIbVH1AUqh5aHPX46HZct1D-tXA8EBIWBwJgZngKr4Kx0BkorQczqNLZ__D74p8ZprGdNbr5ClsIGzf6Dk-imAooUB-mt5m-hgr8GI6Z_gbbqr8Z</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Lee, Karen Mimi</creator><creator>la Fleur, D. Philip</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>DKI</scope><scope>X2L</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070101</creationdate><title>Response to “The common drug review: A NICE start for Canada?” [Health Policy 77(3) (2006) 339–51]</title><author>Lee, Karen Mimi ; la Fleur, D. Philip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-ae8aeb10c36a731a7cdf55cbd2cf1ed9e4ae7a636fc77c3c316565d4aa020f273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Canada</topic><topic>Drug and Narcotic Control - organization &amp; administration</topic><topic>Health administration</topic><topic>Internal Medicine</topic><topic>National Health Programs</topic><topic>Policy Making</topic><topic>Reimbursement Mechanisms - standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Karen Mimi</creatorcontrib><creatorcontrib>la Fleur, D. Philip</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>RePEc IDEAS</collection><collection>RePEc</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Health policy (Amsterdam)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Karen Mimi</au><au>la Fleur, D. Philip</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to “The common drug review: A NICE start for Canada?” [Health Policy 77(3) (2006) 339–51]</atitle><jtitle>Health policy (Amsterdam)</jtitle><addtitle>Health Policy</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>80</volume><issue>1</issue><spage>1</spage><epage>1</epage><pages>1-1</pages><issn>0168-8510</issn><eissn>1872-6054</eissn><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>16597473</pmid><doi>10.1016/j.healthpol.2006.02.006</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-8510
ispartof Health policy (Amsterdam), 2007-01, Vol.80 (1), p.1-1
issn 0168-8510
1872-6054
language eng
recordid cdi_proquest_miscellaneous_68352367
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE; RePEc
subjects Canada
Drug and Narcotic Control - organization & administration
Health administration
Internal Medicine
National Health Programs
Policy Making
Reimbursement Mechanisms - standards
title Response to “The common drug review: A NICE start for Canada?” [Health Policy 77(3) (2006) 339–51]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T05%3A35%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20%E2%80%9CThe%20common%20drug%20review:%20A%20NICE%20start%20for%20Canada?%E2%80%9D%20%5BHealth%20Policy%2077(3)%20(2006)%20339%E2%80%9351%5D&rft.jtitle=Health%20policy%20(Amsterdam)&rft.au=Lee,%20Karen%20Mimi&rft.date=2007-01-01&rft.volume=80&rft.issue=1&rft.spage=1&rft.epage=1&rft.pages=1-1&rft.issn=0168-8510&rft.eissn=1872-6054&rft_id=info:doi/10.1016/j.healthpol.2006.02.006&rft_dat=%3Cproquest_cross%3E68352367%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68352367&rft_id=info:pmid/16597473&rft_els_id=1_s2_0_S0168851006000327&rfr_iscdi=true